Back to Agenda
Big Data 2021: Delivering Transformation in Data-Driven Medicines Regulation
Session Chair(s)
Peter Richard Arlett, MD, FFPM, FRCP
Head Data Analytics and Methods Task Force
European Medicines Agency, Netherlands
A year on from publication of the 10 priority recommendations of the Big Data Task Force, this session will report on implementation, take stock of EU level policy initiatives and discuss how best to deliver transformation to data-driven medicines regulation.
Speaker(s)
A Year on From The Top-Ten Recommendations – Where Are We Now?
Nikolai Constantin Brun, MD
Danish Medicines Agency, Denmark
Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval & Biostatistics
European Commission Policy Initiatives Shaping Data-Driven Medicines Regulation
Ioana-Maria Gligor
European Commission, Belgium
Head of Unit B3
Stakeholder Panel Discussion: Delivering Transformation in Data-Driven Medicines Regulation
Peter Richard Arlett, MD, FFPM, FRCP
European Medicines Agency, Netherlands
Head Data Analytics and Methods Task Force
Contributing Panelist
Marilena Vrana, MA
European Heart Network, Belgium
Manager Patients and Research
Contributing Panelist
Ioana Octavia Agache, DrMed
European Academy of Allergy and Clinical Immunology, Switzerland
Contributing Panelist
Álmath Spooner, PhD
Abbvie, Ireland
Head of Europe Regulatory Policy & Intelligence (RPI)
Contributing Panelist
Representative Invited
MedTech Europe
Contributing Panelist
Helga Gardarsdottir, PhD
Utrecht University, Netherlands
Associate Professor
Have an account?